TELA Bio, Inc. (NasdaqGM: TELA)
Health Care · Health Care Equipment & Supplies · US
$0.65
+0.31% today · -64.7% 1Y
TELA Bio, Inc. (NasdaqGM: TELA) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $29.02M and employs 218 people.
Over the last twelve months the share price has lost 64.7%, trading between 0.50 and 2.00.
Tweenvest scores TELA Bio, Inc. across four factors: quality 19/100, value 56/100. Its strongest factor is value.
TELA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $29.02M
- Revenue (TTM)
- $79.91M
- P/E
- —
- EPS
- -0.78
- Dividend yield
- —
- Beta (5Y)
- 1.36
- 52-week high
- $2.00
- 52-week low
- $0.50
- Avg volume (3M)
- —
- Shares outstanding
- 44.89M
- Employees
- 218
- Next earnings
- —
About TELA Bio, Inc.
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.
- Founded
- 2012
- Listed since
- Nov 7, 2019
- Exchange
- Nasdaq Global Market
- Currency
- USD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $201.83B | $116.85 | +0.18% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $133.83B | $380.60 | +0.47% |
| Stryker CorporationNYSE: SYK | $126.37B | $332.00 | +0.77% |
| Medtronic plcNYSE: MDT | $119.49B | $93.79 | +0.47% |
| EssilorLuxottica Société anonymeENXTPA: EL | $87.56B | €162.35 | -0.52% |
| Boston Scientific CorporationNYSE: BSX | $73.00B | $50.74 | +0.73% |
| HOYA CorporationTSE: 7741 | $52.38B | ¥24,895.00 | -1.37% |
| Becton, Dickinson and CompanyNYSE: BDX | $52.30B | $192.00 | +2.33% |
Figures last refreshed Aug 18, 2026.